Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics - 1 Jul 2015

Chene Gautier, Ouellet Veronique, Rahimi Kurosh, Barres Veronique, Provencher Diane, Mes-Masson Anne Marie

Abstract excerpt

OBJECTIVE: To assess ARID1A-encoded protein (BAF250a) and phosphorylated AKT (pAKT) expression, apoptosis, and the DNA damage response pathway in endometrioid and clear cell ovarian cancers (endometriosis-associated ovarian cancers [EAOCs]), and benign endometriotic ovarian cysts. METHODS: In a retrospective study, tissue samples were reviewed from patients who had undergone surgery for EAOC or endometriotic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Canada

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Endometrioid

Share to DNA Damage

Share to Endometriosis

Share to Endometrium

Share to Nuclear Proteins

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 25912412
DOI: 10.1016/j.ijgo.2015.02.021

Genes

BAX

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.PMID 25912412Read ↗

ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian CarcinomasSemantic proximity Read ↗

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.Semantic proximity Read ↗

Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.Semantic proximity Read ↗

Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?Semantic proximity Read ↗

ARID1A gene mutation in ovarian and endometrial cancers (Review).Semantic proximity Read ↗

Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance.Semantic proximity Read ↗

ARID1A is a useful marker of malignancy in peritoneal washings for endometrial carcinoma.Semantic proximity Read ↗

Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian CancersSemantic proximity Read ↗

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.Semantic proximity Read ↗

Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma.Semantic proximity Read ↗

Establishment of a Novel In Vitro and In Vivo Model to Understand Molecular Carcinogenesis of Endometriosis-Related Ovarian NeoplasmsSemantic proximity Read ↗

Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.